No Data
TRYT Plans Absorption of Medicle Inc.
TRYT Inc. Announces Merger With Medicle Inc. to Enhance Efficiency
Cover, Skymark, ETC [Emerging Markets Rating List]
"Goldman" <4478> Free Sell maintained "Morgan" <5253> Cover OVERWEIGHT maintained <9164> Trite EQUALWEIGHT maintained "Tokai Tokyo" <9204> Skymark NEUTRAL maintained *The ratings of the above companies are as of 02/28 based on our verification.
MonotaRO, Daio Paper, ETC (additional) Rating
Upgrades - Bullish Code Stock Name Broker Previous After ------------------------------------------------------------- <1911> Sumitomo Forestry SMBC Nikko "2" "1" <4062> Ibiden Morgan Stanley "Equal Weight" "Over Weight" <5333> Gaishi Mizuho "Hold" "Buy" Downgrades - Bearish Code Stock Name Broker Previous After ---------------------------
Rating information (Target Price change - Part 2) = Kakaku.com, JACR, ETC.
◎ Mizuho Securities (three-tiered: Buy > Hold > underperform) Kakaku.com <2371.T> --- "Buy" → "Buy", 2900 yen → 2600 yen KH Neochem <4189.T> --- "Buy" → "Buy", 2700 yen → 3200 yen Takeda Pharmaceutical <4502.T> --- "Buy" → "Buy", 5350 yen → 5400 yen Omron <6645.T> --- "Buy" → "Buy", 7000 yen → 6700 yen Panasonic <6752.T> --- "Buy" → "Buy", 2160 yen
Trite is rebounding, and wealth advisors are paying attention to the sales growth of the medical welfare introduction business.
Trihite <9164.T>, which provides human resources services mainly in the medical and welfare fields, rebounded, rising 27 yen to 386 yen as of 9:13 AM. Wealth Advisor published a report on the 28th. The report highlights the company's plan to return to double-digit growth in sales revenue from its core medical and welfare introduction business for the fiscal year ending December 2025. On the profit side, competition for acquiring registered job seekers in the medical and welfare industry is intensifying, and a phase of actively investing in advertising Publicity expenses is expected to continue, leading to a substantial impact on profitability.